Epidemiological and clinical studies suggest that high serum cholesterol is a risk factor of dementia. However, the effects of cholesterol on cognition and brain remain largely unclear. This study aims to investigate the associations between serum total cholesterol (TC) and neuropsychological performance, and intrinsic functional networks in non-demented elderly. Among a cohort of 120 community-dwelling Beijing residents, 29 subjects in the high-TC group (1st quartile) and 31 in the low-TC group (4th quartile) were included in this study, and underwent a battery of neuropsychological tests and magnetic resonance imaging (MRI) scans, including T2- and T1-weighted imaging, and resting-state functional MRI. No significant group difference was found in any of the neuropsychological tests used. Stronger connectivity in the default mode network was observed in the high-TC group compared to that in the low-TC group (p < 0.001, uncorrected). While in the salience network (SN), the high-TC group showed lower connectivity in the anterior cingulate cortex and frontal regions, compared to the low-TC group (p < 0.05, FWE corrected). Our findings suggest that in non-demented elderly persons, high serum cholesterol is associated with disruption of functional connectivity in the SN. The results not only deepen our understanding of how cholesterol affects the brain, but are also significant for selecting sensitive indicators for monitoring the impairments of cholesterol on the neural system.
PfriegerFW (2003) Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci60, 1158–1171.
2.
PapassotiropoulosA, LutjohannD, BagliM, LocatelliS, JessenF, BuschfortR, PtokU, BjorkhemI, von BergmannK, HeunR (2002) 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res36, 27–32.
3.
BuG (2009) Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci10, 333–344.
4.
KivipeltoM, HelkalaEL, LaaksoMP, HanninenT, HallikainenM, AlhainenK, IivonenS, MannermaaA, TuomilehtoJ, NissinenA, SoininenH (2002) Apolipoprotein E epsilon 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med137, 149–155.
AnsteyKJ, LipnickiDM, LowLF (2008) Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry16, 343–354.
7.
AncelinML, RipocheE, DupuyAM, SamieriC, RouaudO, BerrC, CarriereI, RitchieK (2014) Gender-specific associations between lipids and cognitive decline in the elderly. Eur Neuropsychopharmacol24, 1056–1066.
8.
YaffeK, Barrett-ConnorE, LinF, GradyD (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol59, 378–384.
9.
HelznerEP, LuchsingerJA, ScarmeasN, CosentinoS, BrickmanAM, GlymourMM, SternY (2009) Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol66, 343–348.
10.
EliasPK, EliasMF, D’AgostinoRB, SullivanLM, WolfPA (2005) Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med67, 24–30.
11.
SolomonA, KareholtI, NganduT, WolozinB, MacdonaldSW, WinbladB, NissinenA, TuomilehtoJ, SoininenH, KivipeltoM (2009) Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging30, 1006–1009.
12.
CorleyJ, StarrJM, DearyIJ (2015) Serum cholesterol and cognitive functions: The Lothian Birth Cohort 1936. Int Psychogeriatr27, 439–453.
13.
ToroP, DegenC, PiererM, GustafsonD, SchroderJ, SchonknechtP (2014) Cholesterol in mild cognitive impairment and Alzheimer’s disease in a birth cohort over 14 years. Eur Arch Psychiatry Clin Neurosci264, 485–492.
14.
StewartR, WhiteLR, XueQL, LaunerLJ (2007) Twenty-six-year change in total cholesterol levels and incident dementia - The Honolulu-Asia Aging Study. Arch Neurol64, 103–107.
15.
HughesTM, KullerLH, LopezOL, BeckerJT, EvansRW, Sutton-TyrrellK, RosanoC (2012) Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer’s disease. J Alzheimers Dis30, 53–61.
16.
KalariaRN (2012) Cerebrovascular disease and mechanisms of cognitive impairment evidence from clinicopathological studies in humans. Stroke43, 2526–2534.
17.
SolomonA, LeoniV, KivipeltoM, BesgaA, OksengardAR, JulinP, SvenssonL, WahlundLO, AndreasenN, WinbladB, SoininenH, BjorkhemI (2009) Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer’s disease. Neurosci Lett462, 89–93.
18.
Van Den HeuvelMP, Hulshoff PolHE (2010) Exploring the brain network: A review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol20, 519–534.
19.
Della-MaggioreV, SekulerAB, GradyCL, BennettPJ, SekulerR, McIntoshAR (2000) Corticolimbic interactions associated with performance on a short-term memory task are modified by age. J Neurosci20, 8410–8416.
20.
MaddockR, GarrettA, BuonocoreM (2001) Remembering familiar people: The posterior cingulate cortex and autobiographical memory retrieval. Neuroscience104, 667–676.
21.
GreiciusMD, SrivastavaG, ReissAL, MenonV (2004) Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci U S A101, 4637–4642.
22.
ZhouJ, SeeleyWW (2014) Network dysfunction in Alzheimer’s disease and frontotemporal dementia: Implications for psychiatry. Biol Psychiatry75, 565–573.
23.
ZhangMY, KatzmanR, SalmonD, JinH, CaiGJ, WangZY, QuGY, GrantI, YuE, LevyP, et al. (1990) The prevalence of dementia and Alzheimer’s disease in Shanghai, China: Impact of age, gender, and education. Ann Neurol27, 428–437.
24.
GuoQ, ZhaoQ, ChenM, DingD, HongZ (2009) A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer Dis Assoc Disord23, 253–259.
25.
ZhouY, LuJC, GuoQH, HongZ (2006) Rey-Osterriche complex figure test used to identify mild Alzheimer’s disease. Chin J Clin Neurosci14, 501–504.
26.
LuJC, GuoQH, HongZ, ShiWX, LvCZ (2006) Trail making test used by Chinese elderly patients with mild cognitive impairment and mild Alzheimer dementia. Chin J Clin Psychol4, 118–121.
27.
SheridanLK, FitzgeraldHE, AdamsKM, NiggJT, MartelMM, PuttlerLI, WongMM, ZuckerRA (2006) Normative Symbol Digit Modalities Test performance in a community-based sample. Arch Clin Neuropsychol21, 23–28.
28.
IshiaiS, SugishitaM, IchikawaT, GonoS, WatabikiS (1993) Clock-drawing test and unilateral spatial neglect. Neurology43, 106–110.
29.
MokEH, LamLC, ChiuHF (2004) Category verbal fluency test performance in chinese elderly with Alzheimer’s disease. Dement Geriatr Cogn Disord18, 120–124.
30.
GuoQH, HongZ, ShiWX, SunYM, LvCZ (2006) Boston naming test using by Chinese elderly, patient with mild cognitive impairment and Alzheimer’s dementia. Chin Ment Health J20, 81–85.
31.
GuoQH, HongZ, LvCZ, ZhouY, LuJC, DingD (2005) Application of Stroop color-word test on Chinese elderly patients with mild cognitive impairment and mild Alzheimer’s dementia. Chin J Neuromed4, 701–704.
32.
DamoiseauxJS, BeckmannCF, ArigitaEJ, BarkhofF, ScheltensP, StamCJ, SmithSM, RomboutsSA (2008) Reduced resting-state brain activity in the “default network” in normal aging. Cereb Cortex18, 1856–1864.
33.
JonesDT, MachuldaMM, VemuriP, McDadeEM, ZengG, SenjemML, GunterJL, PrzybelskiSA, AvulaRT, KnopmanDS, BoeveBF, PetersenRC, JackCRJr (2011) Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology77, 1524–1531.
34.
ReynoldsCA, GatzM, PrinceJA, BergS, PedersenNL (2010) Serum lipid levels and cognitive change in late life. J Am Geriatr Soc58, 501–509.
35.
MielkeMM, ZandiPP, ShaoH, WaernM, OstlingS, GuoX, BjorkelundC, LissnerL, SkoogI, GustafsonDR (2010) The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology75, 1888–1895.
WangL, ZangY, HeY, LiangM, ZhangX, TianL, WuT, JiangT, LiK (2006) Changes in hippocampal connectivity in the early stages of Alzheimer’s disease: Evidence from resting state fMRI. Neuroimage31, 496–504.
BresslerSL, MenonV (2010) Large-scale brain networks in cognition: Emerging methods and principles. Trends Cogn Sci14, 277–290.
40.
RichesonJA, BairdAA, GordonHL, HeathertonTF, WylandCL, TrawalterS, SheltonJN (2003) An fMRI investigation of the impact of interracial contact on executive function. Nat Neurosci6, 1323–1328.
41.
WaltherK, BirdsillAC, GliskyEL, RyanL (2010) Structural brain differences and cognitive functioning related to body mass index in older females. Hum Brain Mapp31, 1052–1064.
42.
CarterCS, MacdonaldAM, BotvinickM, RossLL, StengerVA, NollD, CohenJD (2000) Parsing executive processes: Strategic vs. evaluative functions of the anterior cingulate cortex. Proc Natl Acad Sci U S A97, 1944–1948.
43.
LiangX, ZouQ, HeY, YangY (2013) Coupling of functional connectivity and regional cerebral blood flow reveals a physiological basis for network hubs of the human brain. Proc Natl Acad Sci U S A110, 1929–1934.
44.
JansenD, JanssenCI, VanmierloT, DederenPJ, van RooijD, ZinnhardtB, NobelenCL, JanssenAL, HafkemeijerA, MutsaersMP, DoedeeAM, KuipersAA, BroersenLM, MulderM, KiliaanAJ (2012) Cholesterol and synaptic compensatory mechanisms in Alzheimer’s disease mice brain during aging. J Alzheimers Dis31, 813–826.
45.
WilliamsVJ, LeritzEC, ShepelJ, McGlincheyRE, MilbergWP, RudolphJL, LipsitzLA, SalatDH (2013) Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum Brain Mapp34, 1826–1841.
46.
KinT, YamanoS, SakuraiR, KajitaniM, OkahashiY, NishiuraN, SaitoY, UenoS (2007) Carotid atherosclerosis is associated with brain atrophy in Japanese elders. Gerontology53, 1–6.
47.
De LeonM, GeorgeA, StylopoulosL, SmithG, MillerD (1989) Early marker for Alzheimer’s disease: The atrophic hippocampus. Lancet334, 672–673.
48.
BraakH, BraakE (1990) Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol80, 479–486.
49.
NearyD, SnowdenJ, MannD (1993) The clinical pathological correlates of lobar atrophy. Dement Geriatr Cogn Disord4, 154–159.
50.
Edwards-LeeT, MillerBL, BensonDF, CummingsJL, RussellGL, BooneK, MenaI (1997) The temporal variant of frontotemporal dementia. Brain120, 1027–1040.
51.
DietschyJM, TurleySD (2004) Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res45, 1375–1397.
52.
BartzokisG (2011) Alzheimer’s disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging32, 1341–1371.
53.
TeunissenC, De VenteJ, Von BergmannK, BosmaH, Van BoxtelM, De BruijnC, JollesJ, SteinbuschH, LütjohannD (2003) Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol Aging24, 147–155.
